METTL3 and Alzheimer disease: Compared to healthy controls, AD brains show substantial downregulation of m6A writers METTL3 (66.7%), METTL14 (74.0%), and WTAP (76.0%), as well as the eraser FTO (60%) and reader YTHDF1 (73.5%).